Johnson & Johnson Liable in Talc Lawsuit
Analysis based on 9 articles · First reported Feb 13, 2026 · Last updated Feb 16, 2026
The verdict against Johnson & Johnson, though a 'token verdict' according to the company, signals continued legal challenges and potential liabilities for the company, impacting investor sentiment. The ongoing litigation and appeals could lead to significant financial payouts and affect Johnson & Johnson's stock performance.
A Pennsylvania jury found Johnson & Johnson liable in a lawsuit, awarding $250,000 to the family of Gayle Emerson, who died from ovarian cancer allegedly caused by the company's talc-based baby powder. The verdict, delivered in the Philadelphia Court of Common Pleas, sided with Emerson's family, who claimed Johnson & Johnson knew its products were dangerous but failed to warn consumers. Johnson & Johnson plans to appeal the decision, stating the claims were 'meritless'. This case is one of over 67,000 lawsuits Johnson & Johnson faces regarding its talc products, with previous attempts to resolve litigation through bankruptcy being rejected. The outcome of these ongoing legal battles could have substantial financial implications for Johnson & Johnson.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard